Vaccine News and Research

Latest Vaccine News and Research

Coronavirus pandemic could be just the “tip of the iceberg” this winter, warns health charity

With experts stating that 120,000 people could perish from Coronavirus in the closing months of the year, a health charity is warning Britain had better brace itself for another crisis – antibiotic resistant infections.

21 Jul 2020

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors’ latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.

21 Jul 2020

China’s progress in developing COVID-19 vaccines could surprise the world, GlobalData says

China is among the leading countries that are aggressively involved in developing vaccines for COVID-19, with one vaccine each from Sinopharm Group and Sinovac Biotech entering Phase 3 clinical development.

21 Jul 2020

Analysis of the SARS-CoV-2 proteome via visual tools

Now, a new study published on the preprint server bioRxiv* in July 2020 shows how this can be advanced at a greater speed by combining experimental results with homology models obtained by high-throughput pipelines. This will help produce new hypotheses that will show novel druggable targets for effective drug development.

21 Jul 2020

Doctor in Israel reinfected with COVID-19 three months after recovering

There is still a lot to learn about coronavirus disease (COVID-19), which is currently ravaging across the globe. Though scientists are slowly gaining a better understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is still unclear if being infected once may provide long-lasting immunity against the novel coronavirus.

20 Jul 2020

New nanoparticle vaccine for SARS-CoV-2 shows protective traits in preclinical study

A new nanoparticle vaccine for SARS-CoV-2, the virus that causes COVID-19, has shown hints of protection and immunity in a preclinical study, safely eliciting the production of antibodies and antiviral T cell responses in mice and pigtail macaques.

20 Jul 2020

An abundance of biomolecules linked to COVID-19 status and severity

Tapping into the potential of the multi-omic method to uncover functional connections between various classes of biomolecules, researchers from notable institutions in the United States have discovered sets of co-varying molecules that shed light on coronavirus disease (COVID-19) pathophysiology and provide treatment opportunities.

20 Jul 2020

COVID-19 vaccine displays protective traits in nonhuman primates

A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion that goes by the acronym LION, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization. These antibodies potently neutralize the virus.

20 Jul 2020

China's Ad5 vectored COVID-19 vaccine safe and induces immune response

A phase 2 trial of an Ad5 vectored COVID-19 vaccine candidate, conducted in China, has found that the vaccine is safe and induces an immune response, according to new research published in The Lancet.

20 Jul 2020

Oxford University and AstraZeneca vaccine against SARS-CoV-2 safe and induces immune response

Promising early stage results from a phase 1/2 clinical trial of the UK's vaccine candidate against SARS-CoV-2 (the virus that causes COVID-19) are published today in The Lancet.

20 Jul 2020

Australian researches detect SARS-CoV-2 virus in wastewater from planes and cruise ships

Previous reports have shown that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), has been found in untreated wastewater. While the data is limited, there are no reported cases of a person becoming infected with the virus due to exposure to contaminated water.

20 Jul 2020

Oxford University and AstraZeneca to publish eagerly-anticipated COVID-19 trial results today

The coronavirus pandemic is still rapidly spreading across the globe, infecting more than 14.44 million people. With more than 188 countries and territories affected, scientists are racing to develop a vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19).

19 Jul 2020

Hydroxychloroquine is not indicated for COVID-19 under any circumstances

The drug Hydroxychloroquine has long been studied as a treatment for malaria and autoimmune diseases. When the coronavirus pandemic spread across the globe, many countries resorted to using the drug in the hopes that it would improve outcomes of hospitalized patients affected by the coronavirus disease (COVID-19).

19 Jul 2020

Benefits of routine childhood immunizations far outweigh the risk of SARS-CoV-2 transmission

The health benefits of maintaining routine childhood vaccination programmes in Africa during the COVID-19 pandemic far outweigh the risk of SARS-CoV-2 transmission that might be associated with clinic visits, according to a modelling study published in The Lancet Global Health journal.

19 Jul 2020

MU offers an alternative to chemotherapy for treatment of cancer in animals and humans

Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cancer cells, the numerous side effects can be painful and often a subset of cancer cells exist that are resistant to chemotherapy.

19 Jul 2020

Researchers detect positive COVID-19 cases in 20 minutes using blood samples

World-first research by Monash University in Australia has been able to detect positive COVID-19 cases using blood samples in about 20 minutes, and identify whether someone has contracted the virus.

17 Jul 2020

Study reveals antiviral effects of curcumin

Curcumin, a natural compound found in the spice turmeric, could help eliminate certain viruses, research has found.

17 Jul 2020

More COVID-19 cases where blood type A is common

Now, a new study by researchers at the University of Ulm, Germany, which is published on the preprint server medRxiv in July 2020, focuses on how blood group distribution is related to the mapped dynamics of the epidemic as shown by its geographical distribution.

17 Jul 2020

Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened, according to results from an Emory Vaccine Center study.

17 Jul 2020

Report calls for customized evidence on optimal implementation of COVID-19 measures

Today a report was released that calls for the use of research evidence on the optimal implementation of public health interventions for COVID-19 in varied global settings.

17 Jul 2020

Vaccine News and Research

Latest Vaccine News and Research

Coronavirus pandemic could be just the “tip of the iceberg” this winter, warns health charity

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

China’s progress in developing COVID-19 vaccines could surprise the world, GlobalData says

Analysis of the SARS-CoV-2 proteome via visual tools

Doctor in Israel reinfected with COVID-19 three months after recovering

New nanoparticle vaccine for SARS-CoV-2 shows protective traits in preclinical study

An abundance of biomolecules linked to COVID-19 status and severity

COVID-19 vaccine displays protective traits in nonhuman primates

China's Ad5 vectored COVID-19 vaccine safe and induces immune response

Oxford University and AstraZeneca vaccine against SARS-CoV-2 safe and induces immune response

Australian researches detect SARS-CoV-2 virus in wastewater from planes and cruise ships

Oxford University and AstraZeneca to publish eagerly-anticipated COVID-19 trial results today

Hydroxychloroquine is not indicated for COVID-19 under any circumstances

Benefits of routine childhood immunizations far outweigh the risk of SARS-CoV-2 transmission

MU offers an alternative to chemotherapy for treatment of cancer in animals and humans

Researchers detect positive COVID-19 cases in 20 minutes using blood samples

Study reveals antiviral effects of curcumin

More COVID-19 cases where blood type A is common

Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

Report calls for customized evidence on optimal implementation of COVID-19 measures

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in